GLP-1
Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced it has expanded its lab facilities by more than 30% to accommodate demand, mainly from US and APAC-based biotech companies.
In a statement issued to the Boston Business Journal, Intarcia expressed both disappointment and a determination to get an approval for ITCA 650.
Researchers with City of Hope have developed a chimeric antigen receptor (CAR) T cell therapy leveraging chlorotoxin, a component of scorpion venom.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
Biotage AB, is pleased to announce the launch of a Good Laboratory Practices software upgrade for Biotage® Extrahera™, their flagship automated sample preparation instrument for Supported Liquid Extraction, Solid Phase Extraction, Phospholipid Depletion and Protein Precipitation.
Clarivate Analytics has pegged 11 drugs set to enter the market this year as potential blockbusters by 2024, meaning each will achieve annual sales of more than $1 billion.
In response to the global health emergency caused by the recent outbreak of coronavirus strain 2019-nCoV, LGC’s SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostic manufacturers and clinical laboratories, is announcing the development of molecular reference materials for coronavirus utilizing their proprietary AccuPlex™ recombinant technology.
Arbor Biosciences announced a partnership with Biosearch Technologies, the complete genomics portfolio of LGC Group.
Global reach extended to major pharma market in Oceania
PRESS RELEASES